Chengzao Sun

发表

A Human Single-Chain Antibody Specific for Integrin α3β1 Capable of Cell Internalization and Delivery of Antitumor Agents

D. Boger, H. Ditzel, P. Wirsching, 2004 .

Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.

Ralph R. Reisfeld, C. Liu, K. Janda, 2006, Cancer research.

Enabling ScFvs as multi-drug carriers: a dendritic approach.

P. Wirsching, K. Janda, Chengzao Sun, 2003, Bioorganic & medicinal chemistry.

The design, synthesis, and evaluation of two universal doxorubicin-linkers: preparation of conjugates that retain topoisomerase II activity.

A. Castellino, C. Ballatore, Amos B. Smith, 2006, Bioorganic & medicinal chemistry letters.

Native chemical ligation derived method for recombinant peptide/protein C-terminal amidation.

Soumitra S Ghosh, Chengzao Sun, B. Forood, 2013, Bioorganic & medicinal chemistry letters.

Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain.

D. Henze, S. Grauer, A. Palani, 2021, Journal of medicinal chemistry.

Syntheses of dendritic linkers containing chlorambucil residues for the preparation of antibody-multidrug immunoconjugates.

P. Wirsching, K. Janda, Chengzao Sun, 2002, Bioorganic & medicinal chemistry letters.

A sulfated, phosphorylated 7 kDa secreted peptide characterized by direct analysis of cell culture media.

Steven W. Taylor, Soumitra S Ghosh, Chengzao Sun, 2008, Journal of proteome research.

Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells.

M. J. Newman, Zijian Guo, A. Castellino, 2006, Bioorganic & medicinal chemistry letters.

Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.

Cheng Liu, C. Liu, K. Janda, 2003, Cancer research.

Enzymatic incorporation of an antibody-activated blue fluorophore into DNA.

R. Lerner, T. Z. Hoffman, P. Wirsching, 2005, Angewandte Chemie.

A human single-chain antibody specific for integrin alpha3beta1 capable of cell internalization and delivery of antitumor agents.

D. Boger, H. Ditzel, P. Wirsching, 2004, Chemistry & biology.

Characterization of a chiral enolate aggregate and observation of 6Li-1H scalar coupling.

P. Williard, Deyu Li, Chengzao Sun, 2008, Journal of the American Chemical Society.

Prevention of drug-induced memory impairment by immunopharmacotherapy.

A. Roberts, Jennifer B Treweek, K. Janda, 2008, Journal of medicinal chemistry.

Solid-phase synthesis of anandamide analogues.

K. Janda, M. Meijler, Sang-Hyeup Lee, 2004, Organic letters.

Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids

Soumitra S Ghosh, B. Gedulin, C. Jodka, 2013, PloS one.

Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics.

Soumitra S Ghosh, C. Jodka, D. Parkes, 2013, Journal of medicinal chemistry.

Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigen.

James Paulson, Kim D Janda, Ola Blixt, 2002, Journal of the American Chemical Society.

Synthesis and biological validation of a ubiquitous quorum-sensing molecule.

Kim D Janda, Michael M Meijler, M. Matsushita, 2004, Angewandte Chemie.

Analysis of an asymmetric addition with a 2:1 mixed lithium amide/n-butyllithium aggregate.

Jia Liu, P. Williard, Deyu Li, 2008, The Journal of organic chemistry.

Aggregation studies of complexes containing a chiral lithium amide and n-Butyllithium.

Jia Liu, P. Williard, Deyu Li, 2008, The Journal of organic chemistry.

Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents

D. Parkes, L. D’Souza, J. Trevaskis, 2015, Diabetes, obesity & metabolism.